Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency: Closing the Gaps in Care
WebcastFaculty
OVERVIEW
Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency: Closing the Gaps in Care is organized by National Association for Continuing Education (NACE) and will be held during Mar 14, 2017 - Mar 13, 2018.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
Chronic obstructive pulmonary disease (COPD) is a common and complex condition that affects millions of Americans. Primary care clinicians see these patients routinely and are familiar with the challenges of diagnosis, assessment, and effective management. Unfortunately, many patients with COPD remain undiagnosed and untreated and continue to suffer functional limitations and reduced quality of life. The disease is also heterogeneous, with multiple pathophysiologic mechanisms, risk factors, and clinical presentations. One contributor to COPD that is widely underrecognized is alpha-1 antitrypsin deficiency (AATD).
This enzyme deficiency is a genetic condition that increases risk for emphysema and other conditions, leading to accelerated decline in lung function and increased mortality. Specific tests and effective therapies for AATD are available and can slow the progression of emphysema in affected patients – but these tests and treatments are often ignored.
This monograph reviews the diagnosis and impact of COPD, the role of AATD, and approaches to the treatment of COPD and AATD in primary care settings.
Conference Objectives are:
• Discuss the pathophysiology of alpha-1 antitrypsin deficiency (AATD)
• Demonstrate how to diagnose AATD patients
• Incorporate AATD testing into chronic obstructive pulmonary disease (COPD) management algorithms
• Evaluate treatment options for patients with AATD
Additional details will be posted as soon as they are available.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
Chronic obstructive pulmonary disease (COPD) is a common and complex condition that affects millions of Americans. Primary care clinicians see these patients routinely and are familiar with the challenges of diagnosis, assessment, and effective management. Unfortunately, many patients with COPD remain undiagnosed and untreated and continue to suffer functional limitations and reduced quality of life. The disease is also heterogeneous, with multiple pathophysiologic mechanisms, risk factors, and clinical presentations. One contributor to COPD that is widely underrecognized is alpha-1 antitrypsin deficiency (AATD).
This enzyme deficiency is a genetic condition that increases risk for emphysema and other conditions, leading to accelerated decline in lung function and increased mortality. Specific tests and effective therapies for AATD are available and can slow the progression of emphysema in affected patients – but these tests and treatments are often ignored.
This monograph reviews the diagnosis and impact of COPD, the role of AATD, and approaches to the treatment of COPD and AATD in primary care settings.
Conference Objectives are:
• Discuss the pathophysiology of alpha-1 antitrypsin deficiency (AATD)
• Demonstrate how to diagnose AATD patients
• Incorporate AATD testing into chronic obstructive pulmonary disease (COPD) management algorithms
• Evaluate treatment options for patients with AATD
Additional details will be posted as soon as they are available.
SPECIALITIES
Pulmonary MedicinePrimary Care
Quick Links